MIM
GNOM icon

Macroview Investment Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Macroview Investment Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-134
Closed -$6.04K – 270
2024
Q3 		$6.04K Hold
134
– – 0.01% 340
2024
Q2 		$5.61K Hold
134
– – 0.01% 351
2024
Q1 		$6.11K Hold
134
– – 0.01% 371
2023
Q4 		$6.21K Buy
+134
New +$5.46K 0.01% 367
2023
Q3 		– Sell
-134
Closed -$6.51K – 825
2023
Q2 		$6.51K Hold
134
– – 0.01% 311
2023
Q1 		$6.62K Hold
134
– – 0.01% 297
2022
Q4 		$6.79K Hold
134
– – 0.01% 292
2022
Q3 		$7K Hold
134
– – 0.01% 266
2022
Q2 		$7K Hold
134
– – 0.01% 290
2022
Q1 		$8K Buy
134
+40
+43% +$2.52K 0.01% 287
2021
Q4 		$7K Hold
94
– – 0.01% 261
2021
Q3 		$8K Hold
94
– – 0.01% 250
2021
Q2 		$9K Buy
+94
New +$8.34K 0.01% 189

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Macroview Investment Management's GNOM Position: Q4 2024 in Review

Macroview Investment Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2024, closing a stake of 134 shares — an estimated $6.04K sold.

Macroview Investment Management first reported a position in GNOM in Q2 2021 and held it in 13 quarters. The position peaked at $9K in Q2 2021. 68 funds tracked by Wall St. Rank hold GNOM as of Q4 2024.

  • Macroview Investment Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 134 Global X Genomics & Biotechnology ETF shares in Q4 2024, an estimated $6.04K.
  • Macroview Investment Management first reported a position in Global X Genomics & Biotechnology ETF in Q2 2021 and held it in 13 quarters.
  • Macroview Investment Management's Global X Genomics & Biotechnology ETF position peaked at $9K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.